Three out of four people (75%) who became ill due to coronavirus have made a full recovery after 12 months, regardless of the severity of their illness. But the remaining 25% one in four still have at least one symptom such as coughing, fatigue and breathlessness. These people with persistent symptoms have antibodies in their bodies associated with autoimmune diseases, a new Canadian scientific study shows
The study found that blood samples from patients with long-term Covid-19, who still suffer from fatigue and shortness of breath a year after the initial infection, show obvious signs of autoimmune disease. This discovery may lead to improved diagnosis and treatment of long-term Covid-19, which is relatively common.
The researchers, led by Assistant Professor Manali Mukherjee of McMaster University in Ontario and Professor Chris Carlsten of the University of British Columbia in Vancouver, who published the paper in the European Respiratory Journal, studied 106 people who had had Covid-19 in 2020-21 and had been hospitalized for it, as well as for comparison purposes 22 healthy people and another 34 who had been sick with another respiratory infection (not coronavirus).
Autoimmune diseases occur when the immune system mistakenly attacks healthy parts of the body, causing diseases such as rheumatoid arthritis and systemic lupus erythematosus. In autoimmune disorders, the body produces self-antibodies that do not target harmful viruses and bacteria, but healthy cells and tissues.
Scientists analysed blood samples and found that nearly 80% of patients with long-standing Covid-19 (none had been diagnosed with an autoimmune condition before the pandemic) had two or more such autoantibodies after three to six months from the initial infection, with this figure dropping to 41% (four in ten people) after a year. On the other hand, almost all healthy volunteers had no such boomerang antibodies in their blood, and self-antibody levels were also relatively low in those who had had a non-Covid respiratory infection months before.
The researchers found that two specific autoantibodies in particular (U1snRNP and SSb-Las), along with other inflammation-causing cytokine proteins, were present in 30% of patients with long Covid-19 after a year, particularly in those who suffered from shortness of breath and persistent fatigue.
Mukerji said that for the majority of patients in our study, even if they had autoantibodies shortly after the initial infection, they were gone after 12 months. But in some patients the autoantibodies persist, and it is these patients who are most likely to continue to suffer symptoms and need medical help. Our findings highlight the need to screen for signs of autoimmune disease in patients with long Covid-19 lasting for a year or more. He said people with Covid-19 symptoms after a year should be referred to a rheumatologist or other specialist in autoimmune disease and no longer necessarily to an internist, pulmonologist or infectious disease specialist.
The researchers will next study patients with very long-term Covid-19 lasting up to two years to see how the autoantibodies change over a longer period of time.
[/P][BR][/P] Source:Contents of this article including associated images are belongs to Cyprus Times
Views & opinions expressed are those of the author and/or Cyprus Times
Source